Panasonic Accuses CardioNexus Of Obscuring Software's Value

Law360, New York (July 16, 2012, 5:35 PM EDT) -- Panasonic Corp. on Sunday accused CardioNexus Corp. and two of its executives of misleading it into buying a minority stake in the medical device manufacturer by misrepresenting the value of and the status of regulatory approval for key software.

The tech giant says it invested $6.5 million in CardioNexus in October 2010 to help progress a new ultrasound diagnostic device called AIDA — which Panasonic had initially and independently developed — that is designed to allow for early detection and prevention of heart disease.

CardioNexus provided...
To view the full article, register now.